Carla Deakin | Associate Director, Office for Market Access
NICE

Carla Deakin, Associate Director, Office for Market Access, NICE

Carla Deakin
Associate Director, Office for Market Access (OMA), National Institute for Health and Care Excellence.                                            

Originally a biomedical scientist in the NHS, Carla spent 25 years in the UK Diagnostics industry, gaining both commercial and healthcare system experience in a variety of roles for a major global healthcare company. During this time, Carla was an active contributor in the UK laboratory diagnostics industry and professional body arena and held a number of industry wide posts including:
o Chair of the executive board of BIVDA (British In-Vitro Diagnostics Association) 2012 – 2014
o Member of the NIHR( National Institute of Heath Research) Diagnostic Evidence Cooperatives selection panel 2012-2013
o Chair of the Corporate Members Executive of the ACBLM( Association for Clinical Biochemistry and Laboratory Medicine) 2009 - 2012
o Member of both the executive and working group of Labs Are Vital UK (cross professional body Laboratory Medicine advocacy group) 2007 - 2012
Carla moved to NICE in February 2014 as Associate Director for the Diagnostics Assessment Programme, focusing in particular on raising the awareness of NICE’s diagnostics activities with external stakeholders and became Associate Director for OMA in January 2017.Carla is a Fellow of Institute of Biomedical Sciences and holds an MSc in Health Economics and Health Policy from the University of Birmingham.

Appearances:



Day One World Pharma Pricing & Market Access EU Congress @ 09:40

Keynote panel: Engaging all key stakeholders to improve access and pricing

  • Overview of European and global initiatives and next steps
  • How can we work better for the patient?
  • Working with payers, patients and pharma to generate value

back to speakers